Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cb9f654ff-k7rjm Total loading time: 0 Render date: 2025-08-14T07:42:13.617Z Has data issue: false hasContentIssue false

Chap. 12 - LIFE-THREATENING CUTANEOUS VIRAL DISEASES

Published online by Cambridge University Press:  07 September 2011

By
Aron J. Gewirtzman ,
Brandon Christianson ,
Anne Marie Tremaine ,
Brenda L. Pellicane  and
Stephen Tyring
Edited by
Ronni Wolf ,
Batya B. Davidovici ,
Jennifer L. Parish  and
Lawrence Charles Parish
Aron J. Gewirtzman
Affiliation:
Albert Einstein College of Medicine
Brandon Christianson
Affiliation:
University of Texas Southwestern Medical Center
Anne Marie Tremaine
Affiliation:
University of California–Irvine School of Medicine
Brenda L. Pellicane
Affiliation:
Wayne State University School of Medicine
Stephen Tyring
Affiliation:
University of Texas Health Science Center
Ronni Wolf
Affiliation:
Kaplan Medical Center, Rehovot, Israel
Batya B. Davidovici
Affiliation:
Kaplan Medical Center, Rehovot, Israel
Jennifer L. Parish
Affiliation:
Jefferson Medical College of Thomas Jefferson University
Lawrence Charles Parish
Affiliation:
Jefferson Medical College of Thomas Jefferson University
Get access

Summary

VIRAL DISEASES frequently have cutaneous manifestations, most of which are self-limited and of little consequence; however, there are occasions when a viral cutaneous disease may be accompanied by systemic manifesttions that can be life threatening. In general, healthy children and adults are at little risk for these severe complications. Persons at highest risk for systemic involvement include patients who are immunosuppressed, as well as neonates, extremely elderly persons, and the undernourished population. Because many viruses have some form of cutaneous exanthem, almost any virus known to have systemic involvement can be considered a dermatological emergency. This chapter focuses mainly on those viruses in which the cutaneous findings would be likely to prompt dermatological investigation in an emergency situation.

HERPES SIMPLEX VIRUS

Presentation and Clinical Features

Herpes simplex virus (HSV) is not typically associated with life-threatening or emergency situations; rather, HSV is better known as an acute, self-limited infection that may recur in certain individuals. In rare instances, fatal and highly morbid complications can arise. Neonates and immunocompromised persons generally make up the vast majority of patients with these poor outcomes, but in extremely rare cases some immunocompetent patients suffer severe complications.

HSV can be divided into two subgroups (HSV-1 and HSV-2) based on molecular and immunologic characteristics. HSV-1 typically causes lesions in the oral mucosa and produces gingivostomatitis and pharyngitis in primary infections. Primary infections of HSV-2 most commonly cause genital lesions and produce acute vulvovaginitis and progenitalis.

Information

Type
Chapter
Information
Emergency Dermatology , pp. 115 - 125
Publisher: Cambridge University Press
Print publication year: 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Book purchase

Temporarily unavailable

References

Kimberlin, DW, Lin, CY, Jacobs, RF, et al. Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics. 2001; 108:230–8.CrossRefGoogle ScholarPubMed
Brown, ZA, Wald, A, Morrow, RA, et al. Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. JAMA. 2003; 289:203–9.CrossRefGoogle ScholarPubMed
Whitley, RJ. Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci USA. 1994; 91:2441–7.CrossRefGoogle ScholarPubMed
Hutto, C, Arvin, A, Jacobs, R, et al. Intrauterine herpes simplex virus infections. J Pediatr. 1987; 110:97–101.CrossRefGoogle ScholarPubMed
Baldwin, S, Whitley, RJ.Intrauterine herpes simplex virus infection. Teratology. 1989; 39:1–10.CrossRefGoogle ScholarPubMed
Florman, AL, Gershon, AA, Blackett, PR, Nahmias, AJ. Intrauterine infection with herpes simplex virus. Resultant congenital malformations. JAMA. 1973; 225:129–32.CrossRefGoogle ScholarPubMed
Stone, KM, Brooks, CA, Guinan, ME, Alexander, ER. National surveillance for neonatal herpes simplex virus infections. Sex Transm Dis. 1989; 16:152–6.CrossRefGoogle ScholarPubMed
Whitley, RJ, Corey, L, Arvin, A, et al. Changing presentation of herpes simplex virus infection in neonates. J Infect Dis. 1988; 158:109–16.CrossRefGoogle ScholarPubMed
Whitley, RJ, Nahmias, AJ, Visintine, AM, et al. The natural history of herpes simplex virus infection of mother and newborn. Pediatrics. 1980; 66:489–94.Google Scholar
Yeager, AS, Arvin, AM. Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes simplex virus. Pediatrics. 1984; 73:188–93.Google ScholarPubMed
Kimberlin, DW. Advances in the treatment of neonatal herpes simplex infections. Rev Med Virol. 2001; 11:157–63.CrossRefGoogle ScholarPubMed
Whitley, RJ, Kimberlin, DW, Roizman, B.Herpes simplex viruses. Clin Infect Dis. 1998; 26:541–53; quiz 54–5.CrossRefGoogle ScholarPubMed
Kimberlin, DW, Lin, CY, Jacobs, RF, et al. Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics. 2001; 108:223–9.CrossRefGoogle ScholarPubMed
Holland, GN. Acquired immunodeficiency syndrome and ophthalmology: the first decade. Am J Ophthalmol. 1992; 114:86–95.CrossRefGoogle ScholarPubMed
Whitley, RJ, Roizman, B.Herpes simplex virus infections. Lancet. 2001; 357:1513–18.CrossRefGoogle ScholarPubMed
Lakeman, FD, Whitley, RJ. Diagnosis of herpes simplex encephalitis: application of polymerase chain reaction to cerebrospinal fluid from brain-biopsied patients and correlation with disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1995; 171:857–63.CrossRefGoogle ScholarPubMed
Whitley, RJ, Soong, SJ, Linneman, C., et al. Herpes simplex encephalitis. Clinical Assessment. JAMA. 1982; 247:317–20.Google ScholarPubMed
Whitley, RJ, Gnann, JW. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002; 359:507–13.CrossRefGoogle ScholarPubMed
Novelli, VM, Atherton, DJ, Marshall, WC. Eczema herpeticum. Clinical and laboratory features. Clin Pediatr (Phila). 1988; 27:231–3.CrossRefGoogle ScholarPubMed
Sanderson, IR, Brueton, , Savage, MO, Harper, JI. Eczema herpeticum: a potentially fatal disease. Br Med J (Clin Res Ed). 1987; 294:693–4.CrossRefGoogle ScholarPubMed
Wakkerman, CT. A fatal case of Kaposi's varicelliform eruption. Dermatologica. 1967; 134:393–4.CrossRefGoogle ScholarPubMed
Wheeler, CE., Abele DC. Eczema herpeticum, primary and recurrent. Arch Dermatol. 1966; 93:162–73.CrossRefGoogle ScholarPubMed
Ingrand, D, Briquet, I, Babinet, JM, et al. Eczema herpeticum of the child. An unusual manifestation of herpes simplex virus infection. Clin Pediatrics (Phila). 1985; 24:660–3.CrossRefGoogle Scholar
Monif, GR, Brunell, PA, Hsiung, GD. Visceral involvement by herpes simplex virus in eczema herpeticum. Am J Dis Child. 1968; 116:324–7.Google ScholarPubMed
Kaufman, B, Gandhi, SA, Louie, E, et al. Herpes simplex virus hepatitis: case report and review. Clin Infect Dis. 1997; 24:334–8.CrossRefGoogle ScholarPubMed
Englund, JA, Fletcher, CV, Balfour, HH. Acyclovir therapy in neonates. J Pediatr. 1991; 119:129–35.CrossRefGoogle ScholarPubMed
Safrin, S, Kemmerly, S, Plotkin, B, et al. Foscarnet-resistant herpes simplex virus infection in patients with AIDS. J Infect Dis. 1994; 169:193–6.CrossRefGoogle ScholarPubMed
Whitley, RJ, Alford, CA, Hirsch, MS, et al. Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med. 1986; 314:144–9.CrossRefGoogle ScholarPubMed
Whitley, R, Lakeman, AD, Nahmias, A, Roizman, B.DNA restriction-enzyme analysis of herpes simplex virus isolates obtained from patients with encephalitis. N Engl J Med. 1982; 307:1060–2.CrossRefGoogle ScholarPubMed
Egawa, H, Inomata, Y, Nakayama, S, et al. Fulminant hepatic failure secondary to herpes simplex virus infection in a neonate: a case report of successful treatment with liver transplantation and perioperative acyclovir. Liver Transpl Surg. 1998; 4:513–15.CrossRefGoogle Scholar
Shanley, CJ, Braun, DK, Brown, K, et al. Fulminant hepatic failure secondary to herpes simplex virus hepatitis. Successful outcome after orthotopic liver transplantation. Transplantation. 1995; 59:145–9.CrossRefGoogle ScholarPubMed
Rebora, A.Life-threatening cutaneous viral diseases. Clin Dermatol. 2005; 23:157–63.CrossRefGoogle ScholarPubMed
Sauerbrei, A, Wutzler, P.Neonatal varicella. J Perinatol. 2001; 21:545–9.CrossRefGoogle ScholarPubMed
,Varicella-related deaths among adults–United States, 1997. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1997; 46(19):409–12.Google Scholar
Grant, RM, Weitzman, SS, Sherman, CG, et al. Fulminant disseminated Varicella Zoster virus infection without skin involvement. J Clin Virol. 2002; 24:7–12.CrossRefGoogle ScholarPubMed
Stratman, E.Visceral zoster as the presenting feature of disseminated herpes zoster. J Am Acad Dermatol. 2002; 46:771–4.CrossRefGoogle ScholarPubMed
Mehta, J, Mahajan, V, Khanna, S.Disseminated zoster with polyneuritis cranialis and motor radiculopathy: letter to editor. Neurol India. 2002; 50:228–9.Google ScholarPubMed
Fehr, T, Bossart, W, Wahl, C, Binswanger, U.Disseminated varicella infection in adult renal allograft recipients: four cases and a review of the literature. Transplantation. 2002; 73:608–11.CrossRefGoogle Scholar
Lauzurica, R, Bayes, B, Frias, C, et al. Disseminated varicella infection in adult renal allograft recipients: role of mycophenolate mofetil. Transplant Proc. 2003; 35:1758–9.CrossRefGoogle ScholarPubMed
Gupta, S, Jain, A, Gardiner, C, Tyring, SK. A rare case of disseminated cutaneous zoster in an immunocompetent patient. BMC Fam Pract. 2005; 6:50.CrossRefGoogle Scholar
Curtis, KK, Connolly, MK, Northfelt, DW. Live, attenuated varicella zoster vaccination of an immunocompromised patient. J Gen Intern Med. 2008; 23:648–9.CrossRefGoogle ScholarPubMed
Kramer, JM, LaRussa, P, Tsai, WC, et al. Disseminated vaccine strain varicella as the acquired immunodeficiency syndrome-defining illness in a previously undiagnosed child. Pediatrics. 2001; 108:E39.CrossRefGoogle Scholar
Levy, O, Orange, JS, Hibberd, P, et al. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis. 2003; 188:948–53.CrossRefGoogle Scholar
Parrino, J, Graham, BS. Smallpox vaccines: past, present, and future. J Allerg Clin Immunol. 2006; 118:1320–6.CrossRefGoogle ScholarPubMed
Nafziger, SD.Smallpox. Crit Care Clin. 2005; 21:739–46, vii.CrossRefGoogle ScholarPubMed
James, WD, Berger, TG, Elston, DM, editors. Andrews' diseases of the skin: clinical dermatology. 10th ed. Philadelphia: WB Saunders: 2006.
Goldstein, JA, Neff, JM, Lane, JM, Koplan, JP. Smallpox vaccination reactions, prophylaxis, and therapy of complications. Pediatrics. 1975; 55:342–7.Google ScholarPubMed
Bultmann, BD, Klingel, K, Sotlar, K, et al. Parvovirus B19: a pathogen responsible for more than hematologic disorders. Virchows Arch. 2003; 442:8–17.Google ScholarPubMed
Jong, EP, Haan, TR, Kroes, AC, et al. Parvovirus B19 infection in pregnancy. J Clin Virol. 2006; 36:1–7.CrossRefGoogle ScholarPubMed
Dembinski, J, Eis-Hubinger, AM, Maar, J, et al. Long term follow up of serostatus after maternofetal parvovirus B19 infection. Arch Dis Child. 2003; 88:219–21.CrossRefGoogle ScholarPubMed
Trotta, M, Azzi, A, Meli, M, et al. Intrauterine parvovirus B19 infection: early prenatal diagnosis is possible. Int J Infect Dis. 2004; 8:130–1.CrossRefGoogle ScholarPubMed
Miller, E, Fairley, CK, Cohen, BJ, Seng, C.Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol. 1998; 105:174–8.CrossRefGoogle ScholarPubMed
Norbeck, O, Papadogiannakis, N, Petersson, K, et al. Revised clinical presentation of parvovirus B19-associated intrauterine fetal death. Clin Infect Dis. 2002; 35:1032–8.CrossRefGoogle ScholarPubMed
Katta, R. Parvovirus B19: a review. Dermatol Clin. 2002; 20:333–42.CrossRefGoogle ScholarPubMed
Adler, SP, Marshall, B. Cytomegalovirus infections. Pediatr Rev. 2007; 28:92–100.CrossRefGoogle ScholarPubMed
Prince, SE, Cunha, BA. Postpericardiotomy syndrome. Heart Lung. 1997; 26:165–8.CrossRefGoogle ScholarPubMed
Griffiths, PD, Walter, S.Cytomegalovirus. Curr Opin Infect Dis. 2005; 18:241–5.CrossRefGoogle ScholarPubMed
Adler, SP, Nigro, G, Pereira, L.Recent advances in the prevention and treatment of congenital cytomegalovirus infections. Semin Perinatol. 2007; 31:10–18.CrossRefGoogle ScholarPubMed
Cunha, BA. Smallpox and measles: historical aspects and clinical differentiation. Infect Dis Clin North Am. 2004; 18:79–100.CrossRefGoogle ScholarPubMed
Caulfield, , Onis, M, Blossner, M, Black, RE. Undernutrition as an underlying cause of child deaths associated with diarrhea, pneumonia, malaria, and measles. Am J Clin Nutr. 2004; 80:193–8.CrossRefGoogle ScholarPubMed
Moss, WJ, Fisher, C, Scott, S, et al. HIV type 1 infection is a risk factor for mortality in hospitalized Zambian children with measles. Clin Infect Dis. 2008; 46:523–7.CrossRefGoogle ScholarPubMed
,Progress in global measles control and mortality reduction, 2000–2006. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 2007; 56(47):1237–41.Google Scholar
Wolfson, LJ, Strebel, PM, Gacic-Dobo, M, et al. Has the 2005 measles mortality reduction goal been achieved? A natural history modelling study. Lancet. 2007; 369:191–200.CrossRefGoogle ScholarPubMed
,Update: recommendations from the Advisory Committee on Immunization Practices (ACIP)regarding administration of combination MMRV vaccine. MMWR Morb Mortal Wkly Rep. 2008; 57:258–60.Google Scholar
Hussey, GD, Klein, M. A randomized, controlled trial of vitamin A in children with severe measles. N Engl J Med. 1990; 323:160–4.CrossRefGoogle ScholarPubMed
Carneiro, SC, Cestari, T, Allen, SH, Ramos e-Silva, M.Viral exanthems in the tropics. Clin Dermatol. 2007; 25:212–20.CrossRefGoogle ScholarPubMed
Santis, M, Cavaliere, AF, Straface, G, Caruso, A. Rubella infection in pregnancy. Reprod Toxicol. 2006; 21:390–8.CrossRefGoogle ScholarPubMed
Gulen, F, Cagliyan, E, Aydinok, Y, et al. A patient with rubella encephalitis and status epilepticus. Minerva Pediatr. 2008; 60:141–4.Google ScholarPubMed
Martinelli, PT, Tyring, SK. Human herpesvirus 8. Dermatol Clin. 2002; 20:307–14, vii–viii.CrossRefGoogle ScholarPubMed
Aldenhoven, M, Barlo, NP, Sanders, CJ. Therapeutic strategies for epidemic Kaposi's sarcoma. Int J STD AIDS. 2006; 17:571–8.CrossRefGoogle ScholarPubMed
Noy, A.Update in Kaposi sarcoma. Curr Opin Oncol. 2003; 15:379–81.CrossRefGoogle ScholarPubMed
Lupi, O, Tyring, SK. Tropical dermatology: viral tropical diseases. J Am Acad Dermatol. 2003; 49:979–1000; quiz, 2.CrossRefGoogle ScholarPubMed
Monath, TP.Yellow fever: an update. Lancet Infect Dis. 200; 1:11–20.CrossRef
Rowe, AK, Bertolli, J, Khan, AS, et al. Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidemies a Kikwit. J Infect Dis. 1999; 179 Suppl 1:S28–35.CrossRefGoogle Scholar
Freed, EO. Virology. Rafting with Ebola. Science. 2002; 296:279.CrossRefGoogle ScholarPubMed
Portela Camara, F. Epidemiology of the Ebola virus: facts and hypotheses. Braz J Infect Dis. 1998; 2:265–8.Google ScholarPubMed
,Update: management of patients with suspected viral hemorrhagic fever–United States. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep. 1995; 44(25):475–9.Google Scholar
Gewirtzman, A, Bartlett, B, Tyring, S.Epidermodysplasia verruciformis and human papilloma virus. Curr Opin Infect Dis. 2008; 21:141–6.CrossRefGoogle ScholarPubMed
Krogstad, P, Cherry, JD. Quadrivalent human vaccine – a call to action and for additional research. Pediatr Res. 2007; 62:527.CrossRefGoogle Scholar
Jappe, U.Amoxicillin-induced exanthema in patients with infectious mononucleosis: allergy or transient immunostimulation?Allergy. 2007; 62:1474–5.CrossRefGoogle ScholarPubMed
Brady, G, MacArthur, GJ, Farrell, PJ. Epstein-Barr virus and Burkitt lymphoma. J Clin Pathol. 2007; 60:1397–402.Google ScholarPubMed
Kapatai, G, Murray, P.Contribution of the Epstein Barr virus to the molecular pathogenesis of Hodgkin lymphoma. J Clin Pathol. 2007; 60:1342–9.CrossRefGoogle ScholarPubMed
Lin, X, Gudgeon, NH, Hui, EP, et al. CD4 and CD8 T cell responses to tumour-associated Epstein-Barr virus antigens in nasopharyngeal carcinoma patients. Cancer Immunol Immunother. 2008; 57:963–75.CrossRefGoogle ScholarPubMed
Cathomas, G. Kaposi's sarcoma-associated herpesvirus (KSHV)/human herpesvirus 8 (HHV-8) as a tumour virus. Herpes. 2003; 10:72–7.Google Scholar
Merican, I, Guan, R, Amarapuka, D, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000; 15:1356–61.CrossRefGoogle ScholarPubMed

Accessibility standard: Unknown

Accessibility compliance for the PDF of this book is currently unknown and may be updated in the future.

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×